BELITE BIO, INC ($BLTE)
Filing Information
| Accession Number | 0001193125-26-414643 |
|---|---|
| Form Type | 4 |
| Filing Date | Oct 5, 2026 |
| Document | View SEC Filing |
Transactions
8
Total Shares
500
Total Value
$82,658.89
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | American depositary share | โ | Oct 1, 2026 | Sale | 200 | $163.62 | $32,725.00 | 14,800 | Indirect | By Bioptima Ltd. | View Details | |
Chief Medical Officer | American depositary share | โ | Oct 1, 2026 | Sale | 24 | $164.64 | $3,951.38 | 14,776 | Indirect | By Bioptima Ltd. | View Details | |
Chief Medical Officer | American depositary share | โ | Oct 1, 2026 | Sale | 120 | $165.49 | $19,859.22 | 14,656 | Indirect | By Bioptima Ltd. | View Details | |
Chief Medical Officer | American depositary share | โ | Oct 1, 2026 | Sale | 50 | $166.44 | $8,321.84 | 14,606 | Indirect | By Bioptima Ltd. | View Details | |
Chief Medical Officer | American depositary share | โ | Oct 1, 2026 | Sale | 78 | $167.59 | $13,071.83 | 14,528 | Indirect | By Bioptima Ltd. | View Details | |
Chief Medical Officer | American depositary share | โ | Oct 1, 2026 | Sale | 12 | $168.21 | $2,018.54 | 14,516 | Indirect | By Bioptima Ltd. | View Details | |
Chief Medical Officer | American depositary share | โ | Oct 1, 2026 | Sale | 14 | $169.36 | $2,371.04 | 14,502 | Indirect | By Bioptima Ltd. | View Details | |
Chief Medical Officer | American depositary share | โ | Oct 1, 2026 | Sale | 2 | $170.02 | $340.04 | 14,500 | Indirect | By Bioptima Ltd. | View Details |